Xilio Therapeutics Competitors and Similar CompaniesClear all
Xilio Therapeutics's competitors and similar companies include Kiromic Biopharma, Kite Pharma, RAPT Therapeutics and Alligator Bioscience.
 Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. |  Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. |  RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | |||
Founding Date | Founding Date 2015 | Founding Date 2012 | Founding Date 2009 | Founding Date 2015 | Founding Date 2001 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Waltham, US HQ | Locations Houston, US HQ | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations South San Francisco, US HQ | Locations Lund, SE HQ |
Employees | Employees 69 | Employees 4426% increase | Employees 3,9671% decrease | Employees 64 | Employees 1555% decrease |
Valuation ($) | Valuation ($) 43.5 m | Valuation ($) 1.8 m | Valuation ($) N/A | Valuation ($) 69.8 m | Valuation ($) 59 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $43.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr514k (FY, 2025) |
Net income | Net income ($35m) (FY, 2025) | Net income ($26.9m) (FY, 2024) | Net income N/A | Net income ($129.9m) (FY, 2024) | Net income (kr51.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 233m | Total funding raised $ 135k | Total funding raised $ 85.3m | Total funding raised $ 176m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Kiromic Biopharma
HQ
Houston, US
Employees
44↑ 26% increase
Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
View company
Kite Pharma
HQ
Santa Monica, US
Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.
View companyRAPT Therapeutics
HQ
South San Francisco, US
Employees
64
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company
Alligator Bioscience
HQ
Lund, SE
Employees
15
Alligator develops antibody-based pharmaceuticals for cancer treatment.
View company